Information regarding Trulicity prices is not available in the provided text.
How is Trulicity prescribed?
Trulicity (dulaglutide) is a once-weekly injection used to improve glycemic control in adults with type 2 diabetes mellitus [1]. It is administered as a subcutaneous injection in the abdomen, thigh, or upper arm [1].
What are the potential side effects of Trulicity?
Common side effects of Trulicity include nausea, vomiting, diarrhea, abdominal pain, and decreased appetite [1]. More serious side effects can include pancreatitis, gallbladder problems, kidney problems, severe allergic reactions, and the risk of thyroid C-cell tumors [1]. Patients should also be aware of the potential for hypoglycemia, especially when used with other diabetes medications like sulfonylureas or insulin [1].
When does Trulicity's patent expire?
The patent expiration dates for Trulicity vary. According to DrugPatentWatch.com, the latest expiring U.S. patent for Trulicity is expected to be in 2027 [2]. However, there are multiple patents covering Trulicity, with various expiration dates [2].
Are there generic versions of Trulicity available?
As of the information available, generic versions of Trulicity are not yet on the market [2]. The exclusivity period for Trulicity is linked to its patent protections, and biosimilar or generic entry is typically not possible before patent expiry [2].
Sources:
1. https://www.trulicity.com/
2. https://drugpatentwatch.com/